Rheinmetall CEO Backs Stock With €502,484 Purchase as Analysts Split on Delayed Guidance

Armin Papperger has put his own money where his forecast is. Rheinmetall's chief executive bought shares worth a total of 502,484.40 EUR, according to a mandatory disclosure published on Friday. The transaction landed after the company's guidance cut and ahead of a capital markets day scheduled for 27 November 2026 — timing that gives the purchase its weight.

The stock still slipped 1.4% on Friday. Neither the insider buy nor the release of quarterly figures was enough to stop the day's decline.

What the cut actually changed

Rheinmetall had already trimmed its full-year outlook on Wednesday, citing the likely delayed award of the Bundeswehr's Arminius project — a Boxer variant — as one reason. Delays in lot acceptances for artillery ammunition added to the drag. Related advance payments and revenue now shift beyond 2027, the company said.

The numbers moved accordingly. Revenue is now guided at around 13.2 bn EUR, down from an earlier range of 13.7–14.2 bn EUR. The expected operating margin came down to roughly 18.5% from around 19%. Rheinmetall confirmed the revised targets in its quarterly statement.

Expected revenue opportunities from new activities also fell short of plan. Rheinmetall singled out its collaboration with Destinus in that regard.

Nine-month momentum versus a softer horizon

Against that backdrop, the growth already booked offers the counterweight. Group revenue for the first nine months of 2026 reached 8.38 bn EUR, up 38% year on year. Operating profit in the period exceeded 1.3 bn EUR, with an operating margin of 16.0%.

The third quarter stood out on its own. Revenue climbed 32% to 3.149 bn EUR, while operating profit rose 62% to 553 Mio. EUR.

For investors, the question is no longer whether Rheinmetall can grow — it is whether the timing of that growth holds. If the deferrals prove temporary, later project contributions can underpin the growth story, provided the extra revenue arrives with workable profitability.

Two banks, two verdicts

UBS kept its buy recommendation on Friday while lowering its price target to 1,100 EUR. The bank argued that more conservative forecasts could bolster credibility — an argument that holds only if Rheinmetall delivers on the revised expectations and makes future guidance more dependable.

Bernstein Research took a harsher line, cutting its target to 1,000 EUR from 1,200 EUR. Among the reasons given were a lack of share-price catalysts and an unclear outlook.

That caution carries weight as long as concrete progress on the deferred business is outstanding. Strong growth can support the valuation when it comes with reliable expectations for the coming periods. If that link stays uncertain, attention shifts from growth potential toward execution risk — and even a conservative forecast only convinces once it is met.

The condition that decides the case

Reliability of planning now matters more than the pure growth question. Last week's cut showed how heavily individual projects can swing the annual expectation. Anyone betting on a recovery is also betting on a more dependable timeline for those contributions.

The negative scenario begins where a one-off deferral turns into recurring planning uncertainty. Should awards or acceptances slip again, investors might have to push expected contributions further out — especially if several of the named revenue sources are hit at once.

As long as the revised annual plan holds and the delayed business stays achievable, a constructive view can rest on operating momentum and later revenue contributions. If the expectation of a time-limited shift breaks down, the cautious case gains ground. Until then, the timing of Rheinmetall's order conversion remains the central yardstick for the stock.